Bionano Genomics, Inc. (BNGO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 983.23M |
| Enterprise Value | 636.03M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 53.18 |
| Price/Book (mrq) | 2.88 |
| Enterprise Value/Revenue | 40.59 |
| Enterprise Value/EBITDA | -11.08 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.87 |
| 52-Week Change 3 | 554.90% |
| S&P500 52-Week Change 3 | 25.02% |
| 52 Week High 3 | 15.6900 |
| 52 Week Low 3 | 0.4900 |
| 50-Day Moving Average 3 | 4.9494 |
| 200-Day Moving Average 3 | 6.2491 |
Share Statistics
| Avg Vol (3 month) 3 | 8.77M |
| Avg Vol (10 day) 3 | 9.84M |
| Shares Outstanding 5 | 289.18M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 280.78M |
| % Held by Insiders 1 | 2.17% |
| % Held by Institutions 1 | 25.31% |
| Shares Short (Nov. 14, 2021) 4 | 37.5M |
| Short Ratio (Nov. 14, 2021) 4 | 4.12 |
| Short % of Float (Nov. 14, 2021) 4 | 12.97% |
| Short % of Shares Outstanding (Nov. 14, 2021) 4 | 12.97% |
| Shares Short (prior month Oct. 14, 2021) 4 | 42.03M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec. 30, 2020 |
| Most Recent Quarter (mrq) | Sep. 29, 2021 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -369.80% |
Management Effectiveness
| Return on Assets (ttm) | -18.06% |
| Return on Equity (ttm) | -34.37% |
Income Statement
| Revenue (ttm) | 15.67M |
| Revenue Per Share (ttm) | 0.06 |
| Quarterly Revenue Growth (yoy) | 112.00% |
| Gross Profit (ttm) | 2.77M |
| EBITDA | -55.88M |
| Net Income Avi to Common (ttm) | -61.22M |
| Diluted EPS (ttm) | -0.2500 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 326.07M |
| Total Cash Per Share (mrq) | 1.13 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 19.32 |
| Book Value Per Share (mrq) | 1.21 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -58.41M |
| Levered Free Cash Flow (ttm) | -28.41M |
